N-[[1-(6-ethyl-5-fluoropyrimidin-4-yl)piperidin-3-yl]methyl]-3,5-dimethyl-1,2-oxazole-4-carboxamide
C18H24FN5O2 — CID 131938393
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[[1-(6-ethyl-5-fluoropyrimidin-4-yl)piperidin-3-yl]methyl]-3,5-dimethyl-1,2-oxazole-4-carboxamide
N-[[1-(6-ethyl-5-fluoropyrimidin-4-yl)piperidin-3-yl]methyl]-3,5-dimethyl-1,2-oxazole-4-carboxamide (PubChem CID 131938393) has the molecular formula C18H24FN5O2 and a molecular weight of 361.42 g/mol. Its IUPAC name is N-[[1-(6-ethyl-5-fluoropyrimidin-4-yl)piperidin-3-yl]methyl]-3,5-dimethyl-1,2-oxazole-4-carboxamide.
Molecular Properties
| Compound Name | N-[[1-(6-ethyl-5-fluoropyrimidin-4-yl)piperidin-3-yl]methyl]-3,5-dimethyl-1,2-oxazole-4-carboxamide |
|---|---|
| PubChem CID | 131938393 |
| Molecular Formula | C18H24FN5O2 |
| Molecular Weight | 361.42 g/mol |
| Exact Mass | 361.19 |
| IUPAC Name | N-[[1-(6-ethyl-5-fluoropyrimidin-4-yl)piperidin-3-yl]methyl]-3,5-dimethyl-1,2-oxazole-4-carboxamide |
| SMILES | CCc1ncnc(N2CCCC(CNC(=O)c3c(C)noc3C)C2)c1F |
| InChI | InChI=1S/C18H24FN5O2/c1-4-14-16(19)17(22-10-21-14)24-7-5-6-13(9-24)8-20-18(25)15-11(2)23-26-12(15)3/h10,13H,4-9H2,1-3H3,(H,20,25) |
| InChIKey | GIKCYJBNFYKPGJ-UHFFFAOYSA-N |
| XLogP | 2.43 |
| TPSA | 84.15 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 26 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 361.42 |
| LogP ≤ 5 | 2.43 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 131938393 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.